{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:57:54Z","timestamp":1792828674681,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T00:00:00Z","timestamp":1430870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ando.2015.04.003","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T22:14:03Z","timestamp":1435097643000},"page":"228-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Post-surgical management of non-functioning pituitary adenoma"],"prefix":"10.1016","volume":"76","author":[{"given":"Christine","family":"Cortet-Rudelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Bonneville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Borson-Chazot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Clavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Coche Dequ\u00e9ant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Desailloud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Maiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Rohmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Louis","family":"Sadoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Sonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Chanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2015.04.003_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2265.1999.00865.x","article-title":"Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation \u2013\u00a0a follow-up study","volume":"51","author":"Turner","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.04.003_bib0010","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2265.2000.01153.x","article-title":"Non-functioning pituitary adenomas: indications for postoperative radiotherapy","volume":"53","author":"Woollons","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.04.003_bib0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/eje.0.1460179","article-title":"MRI protocol technique in the optimal therapeutic strategy of non-functioning pituitary adenomas","volume":"146","author":"Soto-Ares","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.04.003_bib0020","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1365-2265.2003.01784.x","article-title":"Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth","volume":"58","author":"Greenman","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.04.003_bib0025","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1530\/eje.1.02298","article-title":"Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors","volume":"155","author":"Ferrante","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.04.003_bib0030","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1210\/jc.2005-2552","article-title":"Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma","volume":"91","author":"Dekkers","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.04.003_bib0035","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ijrobp.2006.09.049","article-title":"Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy","volume":"67","author":"van den Bergh","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ando.2015.04.003_bib0040","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3171\/JNS\/2008\/108\/3\/0525","article-title":"Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence","volume":"108","author":"Losa","year":"2008","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ando.2015.04.003_bib0045","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2265.2009.03583.x","article-title":"The natural history of surgically treated but radiotherapy-na\u00efve nonfunctioning pituitary adenomas","volume":"71","author":"O'Sullivan","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.04.003_bib0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1530\/EJE-10-0255","article-title":"Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients","volume":"163","author":"Brochier","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.04.003_bib0055","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1530\/EJE-11-0566","article-title":"Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma?","volume":"165","author":"Reddy","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.04.003_bib0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000339823","article-title":"Natural history of postoperative nonfunctioning pituitary adenomas: a systematic review and meta-analysis","volume":"96","author":"Chen","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ando.2015.04.003_bib0065","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2265.2010.03875.x","article-title":"Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis","volume":"73","author":"Murad","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.04.003_bib0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11102-011-0347-7","article-title":"Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis","volume":"15","author":"Roelfsema","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2015.04.003_bib0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ando.2012.04.002","article-title":"Treatment of nonfunctioning pituitary adenomas: what were the contributions of the last 10 years? A critical view","volume":"73","author":"Pereira","year":"2012","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2015.04.003_bib0080","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1530\/eje.0.1440569","article-title":"Radiotherapy for non-functioning pituitary adenomas","volume":"144","author":"Boelaert","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.04.003_bib0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/B:PITU.0000004801.95086.e2","article-title":"Radiotherapy for non-functioning pituitary tumors \u2013\u00a0when and under what circumstances?","volume":"6","author":"Gittoes","year":"2003","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2015.04.003_bib0090","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.beem.2009.05.005","article-title":"Non-functioning pituitary adenomas","volume":"23","author":"Greenman","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.04.003_bib0095","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3171\/jns.2003.98.2.0359","article-title":"Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index","volume":"98","author":"Tanaka","year":"2003","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ando.2015.04.003_bib0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/EJE-07-0099","article-title":"Relevance of Ki-67 and prognostic factors for recurrence\/progression of gonadotropic adenomas after first surgery","volume":"157","author":"Dubois","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.04.003_bib0105","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.humpath.2011.12.003","article-title":"A classification tree approach for pituitary adenomas","volume":"43","author":"Righi","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ando.2015.04.003_bib0110","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1227\/01.NEU.0000290906.53685.79","article-title":"Study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas","volume":"61","author":"Yamada","year":"2007","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ando.2015.04.003_bib0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2265.2003.01674.x","article-title":"Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently","volume":"58","author":"Bradley","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.04.003_bib0120","first-page":"723","article-title":"Clinically silent corticotroph tumors of the pituitary gland","volume":"47","author":"Scheithauer","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ando.2015.04.003_bib0125","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1227\/01.NEU.0000088660.16904.F7","article-title":"Clinical characteristics of silent corticotrophic adenomas and creation of an internet-accessible database to facilitate their multi-institutional study","volume":"53","author":"Webb","year":"2003","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ando.2015.04.003_bib0130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12672-010-0014-x","article-title":"Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes","volume":"1","author":"Cooper","year":"2010","journal-title":"Horm Cancer"},{"key":"10.1016\/j.ando.2015.04.003_bib0135","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3171\/jns.2003.98.5.1084","article-title":"Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion","volume":"98","author":"Trouillas","year":"2003","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ando.2015.04.003_bib0140","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1750-3639.2012.00599.x","article-title":"Clinicopathological correlations in pituitary adenomas","volume":"22","author":"Mete","year":"2012","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ando.2015.04.003_bib0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","article-title":"A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up","volume":"126","author":"Trouillas","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ando.2015.04.003_bib0150","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1210\/jc.2011-3163","article-title":"Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study","volume":"97","author":"Ram\u00edrez","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.04.003_bib0155","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3171\/2008.4.17517","article-title":"Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression","volume":"111","author":"Widhalm","year":"2009","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ando.2015.04.003_bib0160","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1530\/EJE-09-1100","article-title":"MIB-1 labeling index correlated with magnetic resonance imaging detected tumor volume doubling time in pituitary adenoma","volume":"162","author":"Hsu","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.04.003_bib0165","first-page":"96","article-title":"Expression of somatostatin receptor subtypes in primary and recurrent gonadotropinomas: are somatostatin receptors involved in pituitary adenoma recurrence?","volume":"32","author":"Pisarek","year":"2011","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.ando.2015.04.003_bib0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12022-012-9197-8","article-title":"Expression and clinical significance of Wnt players and survivin in pituitary tumours","volume":"23","author":"Formosa","year":"2012","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.ando.2015.04.003_bib0175","first-page":"CR457","article-title":"Altered cyclin D1 genotype distribution in human sporadic pituitary adenomas","volume":"13","author":"Gazioglu","year":"2007","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ando.2015.04.003_bib0180","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1677\/joe.1.06992","article-title":"Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours","volume":"191","author":"Onofri","year":"2006","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ando.2015.04.003_bib0185","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1750-3639.2012.00578.x","article-title":"Endothelial expression of endocan is strongly associated with tumor progression in pituitary adenoma","volume":"22","author":"Cornelius","year":"2012","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ando.2015.04.003_bib0190","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1677\/ERC-10-0018","article-title":"Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis","volume":"17","author":"Galland","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2015.04.003_bib0195","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2010.02.043","article-title":"Proliferation markers of human pituitary tumors: contribution of a genome-wide transcriptome approach","volume":"326","author":"Wierinckx","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ando.2015.04.003_bib0200","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-014-1479-1","article-title":"Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas","volume":"119","author":"Feng","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ando.2015.04.003_bib0205","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.humpath.2014.08.006","article-title":"Overexpression of the cell adhesion molecule claudin-9 is associated with invasion in pituitary oncocytomas","volume":"45","author":"Hong","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ando.2015.04.003_bib0210","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.lpm.2008.09.014","article-title":"Imaging of pituitary adenomas","volume":"38","author":"Bonneville","year":"2009","journal-title":"Presse Med"},{"key":"10.1016\/j.ando.2015.04.003_bib0215","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s007010200064","article-title":"Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma","volume":"144","author":"Kremer","year":"2002","journal-title":"Acta Neurochir (Vienna)"},{"key":"10.1016\/j.ando.2015.04.003_bib0220","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1210\/jc.2008-0643","article-title":"Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas","volume":"93","author":"Dekkers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.04.003_bib0225","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1993.tb02137.x","article-title":"The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas","volume":"38","author":"Brada","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.04.003_bib0230","first-page":"398","article-title":"Influence of radiotherapy on long-term relapse in clinically non-secreting pituitary adenomas. A retrospective study (1970\u20131988)","volume":"2","author":"Jaffrain-Rea","year":"1993","journal-title":"Eur J Med"},{"key":"10.1016\/j.ando.2015.04.003_bib0235","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0360-3016(92)90941-A","article-title":"Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors","volume":"30","author":"Tsang","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ando.2015.04.003_bib0240","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2265.1998.00393.x","article-title":"Radiotherapy for non-function pituitary tumours","volume":"48","author":"Gittoes","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.04.003_bib0245","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1227\/01.NEU.0000126885.71242.D7","article-title":"The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas","volume":"55","author":"Park","year":"2004","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ando.2015.04.003_bib0250","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1530\/EJE-09-0572","article-title":"Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy","volume":"161","author":"Olsson","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.04.003_bib0255","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3171\/jns.1998.89.6.0933","article-title":"Radiotherapy for nonfunctional pituitary adenoma: analysis of long-term tumor control","volume":"89","author":"Breen","year":"1998","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ando.2015.04.003_bib0260","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/1097-0142(19890615)63:12<2409::AID-CNCR2820631206>3.0.CO;2-M","article-title":"Radiotherapy of nonfunctional adenomas of the pituitary gland. Results with long-term follow-up","volume":"63","author":"Flickinger","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ando.2015.04.003_bib0265","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0360-3016(01)01535-8","article-title":"Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland","volume":"50","author":"Milker-Zabel","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ando.2015.04.003_bib0270","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ijrobp.2004.07.688","article-title":"Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas","volume":"61","author":"Paek","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ando.2015.04.003_bib0275","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijrobp.2004.09.058","article-title":"Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients","volume":"62","author":"Colin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ando.2015.04.003_bib0280","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2265.2006.02506.x","article-title":"Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas","volume":"64","author":"Minniti","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.04.003_bib0285","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2265.2009.03755.x","article-title":"Outcome of fractionated stereotactic radiotherapy in patients with pituitary adenomas resistant to conventional treatments: a 5.25-year follow-up study","volume":"73","author":"Schalin-J\u00e4ntti","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.04.003_bib0290","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3171\/jns.2002.97.supplement_5.0429","article-title":"Efficacy of gamma knife radiosurgery for nonfunctioning pituitary adenomas: a quantitative follow-up with magnetic resonance imaging-based volumetric analysis","volume":"97","author":"Wowra","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ando.2015.04.003_bib0295","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3171\/jns.2002.97.supplement_5.0408","article-title":"Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma","volume":"97","author":"Sheehan","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ando.2015.04.003_bib0300","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1227\/01.NEU.0000068702.00330.47","article-title":"Gamma knife radiosurgery for pituitary adenoma: early results","volume":"53","author":"Petrovich","year":"2003","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ando.2015.04.003_bib0305","first-page":"777","article-title":"The usefulness of adjuvant therapy using gamma knife radiosurgery for the recurrent or residual nonfunctioning pituitary adenomas","volume":"33","author":"Iwai","year":"2005","journal-title":"No Shinkei Geka"},{"issue":"Suppl.","key":"10.1016\/j.ando.2015.04.003_bib0310","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3171\/sup.2005.102.s_supplement.0071","article-title":"Radiosurgery and the prevention of regrowth of incompletely removed nonfunctioning pituitary adenomas","volume":"102","author":"Picozzi","year":"2005","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ando.2015.04.003_bib0315","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3171\/jns.2006.104.6.876","article-title":"Gamma surgery in the treatment of nonsecretory pituitary macroadenoma","volume":"104","author":"Mingione","year":"2006","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ando.2015.04.003_bib0320","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00701-007-1253-7","article-title":"Gamma knife radiosurgery for endocrine-inactive pituitary adenomas","volume":"149","author":"Lisc\u00e1k","year":"2007","journal-title":"Acta Neurochir (Vienna)"},{"key":"10.1016\/j.ando.2015.04.003_bib0325","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.ijrobp.2007.08.018","article-title":"Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experience","volume":"70","author":"Pollock","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ando.2015.04.003_bib0330","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11102-008-0163-x","article-title":"Adjuvant gamma knife radiosurgery in non-functioning pituitary adenomas; low risk of long-term complications in selected patients","volume":"12","author":"H\u00f6ybye","year":"2009","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2015.04.003_bib0335","first-page":"623","article-title":"The role of radiation therapy in the management of non-functioning pituitary adenomas","volume":"34","author":"Losa","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2015.04.003_bib0340","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jocn.2011.07.025","article-title":"A single centre's experience of stereotactic radiosurgery and radiotherapy for non-functioning pituitary adenomas with the linear accelerator (LINAC)","volume":"19","author":"Wilson","year":"2012","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.ando.2015.04.003_bib0345","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3171\/2013.3.JNS12766","article-title":"Gamma knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study","volume":"119","author":"Sheehan","year":"2013","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ando.2015.04.003_bib0350","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3171\/2013.11.JNS131757","article-title":"Initial gamma knife radiosurgery for nonfunctioning pituitary adenomas","volume":"120","author":"Lee","year":"2014","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ando.2015.04.003_bib0355","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1530\/EJE-13-0400","article-title":"Gamma knife surgery for patients with volumetric classification of nonfunctioning pituitary adenomas: a systematic review and meta-analysis","volume":"169","author":"Chen","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.04.003_bib0360","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/neuonc\/nor055","article-title":"Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity","volume":"13","author":"Iwata","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ando.2015.04.003_bib0365","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.radonc.2009.09.011","article-title":"Radiotherapy for pituitary adenomas: long-term efficacy and toxicity","volume":"93","author":"Erridge","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ando.2015.04.003_bib0370","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/jc.2004-1152","article-title":"Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years","volume":"90","author":"Minniti","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.04.003_bib0375","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00701-010-0694-6","article-title":"Sarcoma of the sella after radiotherapy for pituitary adenoma","volume":"152","author":"Berkmann","year":"2010","journal-title":"Acta Neurochir (Vienna)"},{"key":"10.1016\/j.ando.2015.04.003_bib0380","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2265.2008.03464.x","article-title":"Neurocognitive consequences of surgery and radiotherapy for tumours of the pituitary","volume":"70","author":"Tooze","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.04.003_bib0385","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2007.01.017","article-title":"Radiotherapy is not associated with reduced quality of life and cognitive function in patients treated for nonfunctioning pituitary adenoma","volume":"68","author":"van Beek","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ando.2015.04.003_bib0390","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijrobp.2006.08.071","article-title":"Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data?","volume":"67","author":"Schultz-Hector","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ando.2015.04.003_bib0395","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-2265.2011.04300.x","article-title":"Does pituitary radiotherapy increase the risk of stroke and, if so, what preventative actions should be taken?","volume":"76","author":"Ayuk","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.04.003_bib0400","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2353\/ajpath.2006.050409","article-title":"Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-\/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage","volume":"168","author":"Stewart","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ando.2015.04.003_bib0405","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0360-3016(99)00159-5","article-title":"The incidence of cerebrovascular accidents in patients with pituitary adenoma","volume":"45","author":"Brada","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ando.2015.04.003_bib0410","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3857\/roj.2011.29.3.156","article-title":"Radiotherapy for pituitary adenomas: long-term outcome and complications","volume":"29","author":"Rim","year":"2011","journal-title":"Radiat Oncol J"},{"issue":"Suppl.","key":"10.1016\/j.ando.2015.04.003_bib0415","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.canrad.2012.01.004","article-title":"Pituitary adenomas: multimodal management and modern irradiation techniques","volume":"16","author":"Chand-Fouch\u00e9","year":"2012","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ando.2015.04.003_bib0420","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3171\/2012.2.JNS111630","article-title":"Cranial nerve dysfunction following gamma knife surgery for pituitary adenomas: long-term incidence and risk factors","volume":"116","author":"Cifarelli","year":"2012","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ando.2015.04.003_bib0425","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0360-3016(02)04380-8","article-title":"A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery","volume":"55","author":"Stafford","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ando.2015.04.003_bib0430","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1227\/NEU.0000000000000457","article-title":"Dose-volume analysis of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery","volume":"75","author":"Pollock","year":"2014","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ando.2015.04.003_bib0435","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0360-3016(93)90230-S","article-title":"Tolerance of cranial nerves of the cavernous sinus to radiosurgery","volume":"27","author":"Tishler","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ando.2015.04.003_bib0440","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1227\/01.NEU.0000124750.13721.94","article-title":"Gamma knife radiosurgery for benign cavernous sinus tumors: quantitative analysis of treatment outcomes","volume":"54","author":"Kuo","year":"2004","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ando.2015.04.003_bib0445","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000085544","article-title":"Gamma knife radiosurgery for tumors involving the cavernous sinus","volume":"83","author":"Liu","year":"2005","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1016\/j.ando.2015.04.003_bib0450","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/WNO.0b013e3181a57d19","article-title":"Ocular neuromyotonia after gamma knife stereotactic radiation therapy","volume":"29","author":"Much","year":"2009","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ando.2015.04.003_bib0455","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3171\/jns.2002.97.supplement_5.0415","article-title":"Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function","volume":"97","author":"Feigl","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ando.2015.04.003_bib0460","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1227\/01.NEU.0000370978.31405.A9","article-title":"Factors associated with endocrine deficits after stereotactic radiosurgery of pituitary adenomas","volume":"67","author":"Leenstra","year":"2010","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ando.2015.04.003_bib0465","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1530\/EJE-10-0733","article-title":"Is it possible to avoid hypopituitarism after irradiation of pituitary adenomas by the Leksell gamma knife?","volume":"164","author":"Marek","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"Suppl. 1","key":"10.1016\/j.ando.2015.04.003_bib0470","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000056449","article-title":"Cerebral infarction with ICA occlusion after gamma knife radiosurgery for pituitary adenoma: a case report","volume":"72","author":"Lim","year":"1999","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1016\/j.ando.2015.04.003_bib0475","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1227\/01.NEU.0000064809.59806.E8","article-title":"Second tumors after radiosurgery: tip of the iceberg or a bump in the road?","volume":"52","author":"Loeffler","year":"2003","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ando.2015.04.003_bib0480","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jocn.2012.09.032","article-title":"Undifferentiated sarcoma of the cavernous sinus after \u03b3 knife radiosurgery for pituitary adenoma","volume":"20","author":"Sasagawa","year":"2013","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.ando.2015.04.003_bib0485","doi-asserted-by":"crossref","first-page":"A19","DOI":"10.1227\/01.NEU.0000341630.42160.18","article-title":"Hypofractionated CyberKnife radiosurgery for perichiasmatic pituitary adenomas: early results","volume":"64","author":"Killory","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ando.2015.04.003_bib0490","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1210\/jc.2003-030859","article-title":"Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment","volume":"89","author":"Pivonello","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.04.003_bib0495","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11102-011-0316-1","article-title":"Dopamine 2 receptor expression in various pathological types of clinically non-functioning pituitary adenomas","volume":"15","author":"Gabalec","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2015.04.003_bib0500","article-title":"Dopamine receptor subtype 2 expression profile in non-functioning pituitary adenomas and in vivo response to cabergoline therapy","author":"Neto","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.04.003_bib0505","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1530\/eje.1.02313","article-title":"Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas","volume":"156","author":"Taboada","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.04.003_bib0510","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2265.2005.02295.x","article-title":"Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth","volume":"63","author":"Greenman","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.04.003_bib0515","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1677\/ERC-08-0181","article-title":"Medical therapy for clinically non-functioning pituitary adenomas","volume":"15","author":"Colao","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2015.04.003_bib0520","first-page":"1416","article-title":"Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy","volume":"79","author":"Pl\u00f6ckinger","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.04.003_bib0525","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2265.1997.3361119.x","article-title":"Somatostatin receptor imaging in somatotroph and non-functioning pituitary adenomas: correlation with hormonal and visual responses to octreotide","volume":"47","author":"Broson-Chazot","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.04.003_bib0530","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2265.2001.01172.x","article-title":"In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically non-functioning pituitary adenomas","volume":"54","author":"Andersen","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2015.04.003_bib0535","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1677\/ERC-06-0026","article-title":"Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion","volume":"14","author":"Zatelli","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2015.04.003_bib0540","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1677\/ERC-09-0101","article-title":"Activation of RAF\/MEK\/ERK and PI3K\/AKT\/mTOR pathways in pituitary adenomas and their effects on downstream effectors","volume":"16","author":"Dworakowska","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2015.04.003_bib0545","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1158\/0008-5472.CAN-09-2951","article-title":"The somatostatin analogue octreotide confers sensitivity to rapamycin treatment on pituitary tumor cells","volume":"70","author":"Cerovac","year":"2010","journal-title":"Cancer Res"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426615000967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426615000967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:48:10Z","timestamp":1757717290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426615000967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":109,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0003426615000967"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2015.04.003","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-surgical management of non-functioning pituitary adenoma","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2015.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2015.04.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2015.04.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2015.04.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2015.04.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2015.04.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}